학술논문
전자자료 공정이용 안내
우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.
공정이용 지침
- 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
- 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
- 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
- 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
- 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
- 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
- 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
- 상업적·영리적 목적으로 자료를 전송·복제·활용
- ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
- EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
- 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
- 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
- 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문'
에서 검색결과 6건 | 목록
1~20
Academic Journal
Edwige Lorthiois; James Roache; David Barnes-Seeman; Eva Altmann; Ulrich Hassiepen; Gordon Turner; Rohit Duvadie; Viktor Hornak; Rajeshri G. Karki; Nikolaus Schiering; Wilhelm A. Weihofen; Francesca Perruccio; Amy Calhoun; Tanzina Fazal; Darija Dedic; Corinne Durand; Solene Dussauge; Kamal Fettis; Fabien Tritsch; Celine Dentel; Adelaide Druet; Donglei Liu; Louise Kirman; Julie Lachal; Kenji Namoto; Douglas Bevan; Rose Mo; Gabriela Monnet; Lionel Muller; Richard Zessis; Xueming Huang; Loren Lindsley; Treeve Currie; Yu-Hsin Chiu; Cary Fridrich; Peter Delgado; Shuangxi Wang; Micah Hollis-Symynkywicz; Joerg Berghausen; Eric Williams; Hong Liu; Guiqing Liang; Hyungchul Kim; Peter Hoffmann; Andreas Hein; Paul Ramage; Allan D’Arcy; Stefanie Harlfinger; Martin Renatus; Simon Ruedisser; David Feldman; Jason Elliott; Richard Sedrani; Juergen Maibaum; Christopher M. Adams
Journal of Medicinal Chemistry. 63:8088-8113
Academic Journal
Angewandte Chemie. 128:10439-10442
Academic Journal
Regard JB; Cardiovascular and Metabolic Diseases, Cambridge, MA, USA.; Harrison TJ; Global Discovery Chemistry, Cambridge, MA, USA.; Axford J; Global Discovery Chemistry, Cambridge, MA, USA.; Axford L; Cardiovascular and Metabolic Diseases, Cambridge, MA, USA. Electronic address: laura.axford@novartis.com.; Lee L; Cardiovascular and Metabolic Diseases, Cambridge, MA, USA.; Ren X; Cardiovascular and Metabolic Diseases, Cambridge, MA, USA.; Deng L; PK Sciences, Cambridge, MA, USA.; Reynolds A; Technical R&D, Cambridge, MA, USA.; Mao J; Global Discovery Chemistry, Cambridge, MA, USA.; Liu Q; Global Discovery Chemistry, Cambridge, MA, USA.; Patnaik A; Global Discovery Chemistry, Cambridge, MA, USA.; Cohick E; Cardiovascular and Metabolic Diseases, Cambridge, MA, USA.; Hollis-Symynkywicz M; Cardiovascular and Metabolic Diseases, Cambridge, MA, USA.; Loi S; Cardiovascular and Metabolic Diseases, Cambridge, MA, USA.; Riek S; Novartis Institutes for BioMedical Research, Autoimmunity, Transplantation and Inflammation, Switzlerland.; McKeever U; Novartis Institutes for BioMedical Research, Autoimmunity, Transplantation and Inflammation, Switzlerland.; Dunstan D; Global Discovery Chemistry, Cambridge, MA, USA.; Sung M; Global Discovery Chemistry, Cambridge, MA, USA.; Ware NF; Global Discovery Chemistry, Cambridge, MA, USA.; Brown AP; Preclinical Safety, Novartis Institutes for BioMedical Research, Fabrikstrasse 2 Novartis Campus, Basel CH-4056, Switzerland.; Hamann LG; Global Discovery Chemistry, Cambridge, MA, USA.; Marcinkeviciene J; Cardiovascular and Metabolic Diseases, Cambridge, MA, USA.; Patterson AW; Global Discovery Chemistry, Cambridge, MA, USA.; Marro ML; Cardiovascular and Metabolic Diseases, Cambridge, MA, USA.
Publisher: Elsevier Science Country of Publication: England NLM ID: 0101032 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2968 (Electronic) Linking ISSN: 00062952 NLM ISO Abbreviation: Biochem Pharmacol Subsets: MEDLINE
Academic Journal
Patnaik A; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Cambridge, MA 02139, United States. Electronic address: anup.patnaik@novartis.com.; Axford L; Cardiovascular and Metabolic Diseases, Novartis Institutes for BioMedical Research, Cambridge, MA 02139, United States.; Deng L; PK Sciences, Novartis Institutes for BioMedical Research, Cambridge, MA 02139, United States.; Cohick E; Cardiovascular and Metabolic Diseases, Novartis Institutes for BioMedical Research, Cambridge, MA 02139, United States.; Ren X; Cardiovascular and Metabolic Diseases, Novartis Institutes for BioMedical Research, Cambridge, MA 02139, United States.; Loi S; Cardiovascular and Metabolic Diseases, Novartis Institutes for BioMedical Research, Cambridge, MA 02139, United States.; Kecman S; Cardiovascular and Metabolic Diseases, Novartis Institutes for BioMedical Research, Cambridge, MA 02139, United States.; Hollis-Symynkywicz M; Cardiovascular and Metabolic Diseases, Novartis Institutes for BioMedical Research, Cambridge, MA 02139, United States.; Harrison TJ; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Cambridge, MA 02139, United States.; Papillon JPN; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Cambridge, MA 02139, United States.; Dales N; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Cambridge, MA 02139, United States.; Hamann LG; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Cambridge, MA 02139, United States.; Lee L; Cardiovascular and Metabolic Diseases, Novartis Institutes for BioMedical Research, Cambridge, MA 02139, United States.; Regard JB; Cardiovascular and Metabolic Diseases, Novartis Institutes for BioMedical Research, Cambridge, MA 02139, United States.; Marcinkeviciene J; Cardiovascular and Metabolic Diseases, Novartis Institutes for BioMedical Research, Cambridge, MA 02139, United States.; Marro ML; Cardiovascular and Metabolic Diseases, Novartis Institutes for BioMedical Research, Cambridge, MA 02139, United States.; Patterson AW; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Cambridge, MA 02139, United States. Electronic address: andrew.patterson@novartis.com.
Publisher: Elsevier Science Country of Publication: England NLM ID: 9413298 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1464-3391 (Electronic) Linking ISSN: 09680896 NLM ISO Abbreviation: Bioorg Med Chem Subsets: MEDLINE
Academic Journal
Academic Journal
Marro ML; Cardiovascular and Metabolic Diseases (M.L.M., L.L., X.R., L.Ax., M.H.-S., N.C., D.C., L.Am., S.L., L.Z., T.H., J.M., J.B.R.), Global Discovery Chemistry (A.W.P., A.P., T.J.H., J.P.N.P., L.G.H.), PK Sciences (L.D.), Technical R&D (A.R.), and Chemical Biology and Therapeutics (J.B.), Novartis Institutes for BioMedical Research, Cambridge, Massachusetts.; Patterson AW; Cardiovascular and Metabolic Diseases (M.L.M., L.L., X.R., L.Ax., M.H.-S., N.C., D.C., L.Am., S.L., L.Z., T.H., J.M., J.B.R.), Global Discovery Chemistry (A.W.P., A.P., T.J.H., J.P.N.P., L.G.H.), PK Sciences (L.D.), Technical R&D (A.R.), and Chemical Biology and Therapeutics (J.B.), Novartis Institutes for BioMedical Research, Cambridge, Massachusetts.; Lee L; Cardiovascular and Metabolic Diseases (M.L.M., L.L., X.R., L.Ax., M.H.-S., N.C., D.C., L.Am., S.L., L.Z., T.H., J.M., J.B.R.), Global Discovery Chemistry (A.W.P., A.P., T.J.H., J.P.N.P., L.G.H.), PK Sciences (L.D.), Technical R&D (A.R.), and Chemical Biology and Therapeutics (J.B.), Novartis Institutes for BioMedical Research, Cambridge, Massachusetts.; Deng L; Cardiovascular and Metabolic Diseases (M.L.M., L.L., X.R., L.Ax., M.H.-S., N.C., D.C., L.Am., S.L., L.Z., T.H., J.M., J.B.R.), Global Discovery Chemistry (A.W.P., A.P., T.J.H., J.P.N.P., L.G.H.), PK Sciences (L.D.), Technical R&D (A.R.), and Chemical Biology and Therapeutics (J.B.), Novartis Institutes for BioMedical Research, Cambridge, Massachusetts.; Reynolds A; Cardiovascular and Metabolic Diseases (M.L.M., L.L., X.R., L.Ax., M.H.-S., N.C., D.C., L.Am., S.L., L.Z., T.H., J.M., J.B.R.), Global Discovery Chemistry (A.W.P., A.P., T.J.H., J.P.N.P., L.G.H.), PK Sciences (L.D.), Technical R&D (A.R.), and Chemical Biology and Therapeutics (J.B.), Novartis Institutes for BioMedical Research, Cambridge, Massachusetts.; Ren X; Cardiovascular and Metabolic Diseases (M.L.M., L.L., X.R., L.Ax., M.H.-S., N.C., D.C., L.Am., S.L., L.Z., T.H., J.M., J.B.R.), Global Discovery Chemistry (A.W.P., A.P., T.J.H., J.P.N.P., L.G.H.), PK Sciences (L.D.), Technical R&D (A.R.), and Chemical Biology and Therapeutics (J.B.), Novartis Institutes for BioMedical Research, Cambridge, Massachusetts.; Axford L; Cardiovascular and Metabolic Diseases (M.L.M., L.L., X.R., L.Ax., M.H.-S., N.C., D.C., L.Am., S.L., L.Z., T.H., J.M., J.B.R.), Global Discovery Chemistry (A.W.P., A.P., T.J.H., J.P.N.P., L.G.H.), PK Sciences (L.D.), Technical R&D (A.R.), and Chemical Biology and Therapeutics (J.B.), Novartis Institutes for BioMedical Research, Cambridge, Massachusetts.; Patnaik A; Cardiovascular and Metabolic Diseases (M.L.M., L.L., X.R., L.Ax., M.H.-S., N.C., D.C., L.Am., S.L., L.Z., T.H., J.M., J.B.R.), Global Discovery Chemistry (A.W.P., A.P., T.J.H., J.P.N.P., L.G.H.), PK Sciences (L.D.), Technical R&D (A.R.), and Chemical Biology and Therapeutics (J.B.), Novartis Institutes for BioMedical Research, Cambridge, Massachusetts.; Hollis-Symynkywicz M; Cardiovascular and Metabolic Diseases (M.L.M., L.L., X.R., L.Ax., M.H.-S., N.C., D.C., L.Am., S.L., L.Z., T.H., J.M., J.B.R.), Global Discovery Chemistry (A.W.P., A.P., T.J.H., J.P.N.P., L.G.H.), PK Sciences (L.D.), Technical R&D (A.R.), and Chemical Biology and Therapeutics (J.B.), Novartis Institutes for BioMedical Research, Cambridge, Massachusetts.; Casson N; Cardiovascular and Metabolic Diseases (M.L.M., L.L., X.R., L.Ax., M.H.-S., N.C., D.C., L.Am., S.L., L.Z., T.H., J.M., J.B.R.), Global Discovery Chemistry (A.W.P., A.P., T.J.H., J.P.N.P., L.G.H.), PK Sciences (L.D.), Technical R&D (A.R.), and Chemical Biology and Therapeutics (J.B.), Novartis Institutes for BioMedical Research, Cambridge, Massachusetts.; Custeau D; Cardiovascular and Metabolic Diseases (M.L.M., L.L., X.R., L.Ax., M.H.-S., N.C., D.C., L.Am., S.L., L.Z., T.H., J.M., J.B.R.), Global Discovery Chemistry (A.W.P., A.P., T.J.H., J.P.N.P., L.G.H.), PK Sciences (L.D.), Technical R&D (A.R.), and Chemical Biology and Therapeutics (J.B.), Novartis Institutes for BioMedical Research, Cambridge, Massachusetts.; Ames L; Cardiovascular and Metabolic Diseases (M.L.M., L.L., X.R., L.Ax., M.H.-S., N.C., D.C., L.Am., S.L., L.Z., T.H., J.M., J.B.R.), Global Discovery Chemistry (A.W.P., A.P., T.J.H., J.P.N.P., L.G.H.), PK Sciences (L.D.), Technical R&D (A.R.), and Chemical Biology and Therapeutics (J.B.), Novartis Institutes for BioMedical Research, Cambridge, Massachusetts.; Loi S; Cardiovascular and Metabolic Diseases (M.L.M., L.L., X.R., L.Ax., M.H.-S., N.C., D.C., L.Am., S.L., L.Z., T.H., J.M., J.B.R.), Global Discovery Chemistry (A.W.P., A.P., T.J.H., J.P.N.P., L.G.H.), PK Sciences (L.D.), Technical R&D (A.R.), and Chemical Biology and Therapeutics (J.B.), Novartis Institutes for BioMedical Research, Cambridge, Massachusetts.; Zhang L; Cardiovascular and Metabolic Diseases (M.L.M., L.L., X.R., L.Ax., M.H.-S., N.C., D.C., L.Am., S.L., L.Z., T.H., J.M., J.B.R.), Global Discovery Chemistry (A.W.P., A.P., T.J.H., J.P.N.P., L.G.H.), PK Sciences (L.D.), Technical R&D (A.R.), and Chemical Biology and Therapeutics (J.B.), Novartis Institutes for BioMedical Research, Cambridge, Massachusetts.; Honda T; Cardiovascular and Metabolic Diseases (M.L.M., L.L., X.R., L.Ax., M.H.-S., N.C., D.C., L.Am., S.L., L.Z., T.H., J.M., J.B.R.), Global Discovery Chemistry (A.W.P., A.P., T.J.H., J.P.N.P., L.G.H.), PK Sciences (L.D.), Technical R&D (A.R.), and Chemical Biology and Therapeutics (J.B.), Novartis Institutes for BioMedical Research, Cambridge, Massachusetts.; Blank J; Cardiovascular and Metabolic Diseases (M.L.M., L.L., X.R., L.Ax., M.H.-S., N.C., D.C., L.Am., S.L., L.Z., T.H., J.M., J.B.R.), Global Discovery Chemistry (A.W.P., A.P., T.J.H., J.P.N.P., L.G.H.), PK Sciences (L.D.), Technical R&D (A.R.), and Chemical Biology and Therapeutics (J.B.), Novartis Institutes for BioMedical Research, Cambridge, Massachusetts.; Harrison TJ; Cardiovascular and Metabolic Diseases (M.L.M., L.L., X.R., L.Ax., M.H.-S., N.C., D.C., L.Am., S.L., L.Z., T.H., J.M., J.B.R.), Global Discovery Chemistry (A.W.P., A.P., T.J.H., J.P.N.P., L.G.H.), PK Sciences (L.D.), Technical R&D (A.R.), and Chemical Biology and Therapeutics (J.B.), Novartis Institutes for BioMedical Research, Cambridge, Massachusetts.; Papillon JPN; Cardiovascular and Metabolic Diseases (M.L.M., L.L., X.R., L.Ax., M.H.-S., N.C., D.C., L.Am., S.L., L.Z., T.H., J.M., J.B.R.), Global Discovery Chemistry (A.W.P., A.P., T.J.H., J.P.N.P., L.G.H.), PK Sciences (L.D.), Technical R&D (A.R.), and Chemical Biology and Therapeutics (J.B.), Novartis Institutes for BioMedical Research, Cambridge, Massachusetts.; Hamann LG; Cardiovascular and Metabolic Diseases (M.L.M., L.L., X.R., L.Ax., M.H.-S., N.C., D.C., L.Am., S.L., L.Z., T.H., J.M., J.B.R.), Global Discovery Chemistry (A.W.P., A.P., T.J.H., J.P.N.P., L.G.H.), PK Sciences (L.D.), Technical R&D (A.R.), and Chemical Biology and Therapeutics (J.B.), Novartis Institutes for BioMedical Research, Cambridge, Massachusetts.; Marcinkeviciene J; Cardiovascular and Metabolic Diseases (M.L.M., L.L., X.R., L.Ax., M.H.-S., N.C., D.C., L.Am., S.L., L.Z., T.H., J.M., J.B.R.), Global Discovery Chemistry (A.W.P., A.P., T.J.H., J.P.N.P., L.G.H.), PK Sciences (L.D.), Technical R&D (A.R.), and Chemical Biology and Therapeutics (J.B.), Novartis Institutes for BioMedical Research, Cambridge, Massachusetts.; Regard JB; Cardiovascular and Metabolic Diseases (M.L.M., L.L., X.R., L.Ax., M.H.-S., N.C., D.C., L.Am., S.L., L.Z., T.H., J.M., J.B.R.), Global Discovery Chemistry (A.W.P., A.P., T.J.H., J.P.N.P., L.G.H.), PK Sciences (L.D.), Technical R&D (A.R.), and Chemical Biology and Therapeutics (J.B.), Novartis Institutes for BioMedical Research, Cambridge, Massachusetts jean.regard@novartis.com.
Publisher: Elsevier Country of Publication: Netherlands NLM ID: 0376362 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-0103 (Electronic) Linking ISSN: 00223565 NLM ISO Abbreviation: J Pharmacol Exp Ther Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Hollis-Symynkywicz, M.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어